Amlodipine: Nursing Drug Guide, Hypotension & Hold Rules

Amlodipine is most widely recognized as Norvasc and is available generically as amlodipine besylate tablets. It is also combined with other antihypertensives in fixed-dose products—always verify the MAR for the exact strength and whether the order is single-entity or combination therapy during medication reconciliation.

Fixed-dose combinations include amlodipine with benazepril (e.g., Lotrel) and other antihypertensive pairings per local formulary. Do not assume a patient knows whether their home tablet is amlodipine alone or part of a combination—duplicate calcium channel blocker therapy with nifedipine or other dihydropyridines increases hypotension risk.

Amlodipine is a long-acting dihydropyridine calcium channel blocker used for hypertension and coronary artery disease. Nurses administer it for blood pressure control and for chronic stable or vasospastic angina when ordered as monotherapy or with other cardiovascular agents.

↔On a small screen, swipe or scroll sideways to see the full table.

Amlodipine blocks L-type calcium channels in vascular smooth muscle, causing peripheral arterial vasodilation and reduced systemic vascular resistance. The resulting drop in blood pressure can trigger baroreceptor-mediated reflex tachycardia. Vasodilation also increases capillary hydrostatic pressure in dependent areas, which explains dose-related peripheral edema—a separate nursing story from hypotension but one patients often report together.

Dosing is once daily. Titrate slowly in elderly patients, hepatic impairment, and when adding interacting drugs. Verify strength (2.5, 5, or 10 mg) against the prescriber order before administration.

Missed dose: If a dose is missed, give it when remembered unless near the next scheduled dose—do not double doses. After a missed day, reassess blood pressure before restarting if the patient felt dizzy or had low readings at home.

Pretreatment checks

• Obtain supine and standing blood pressure using proper blood pressure measurement technique—especially before the first inpatient dose or after any dose increase
• Review history of syncope, volume depletion, severe aortic stenosis, recent MI, unstable angina, hepatic impairment, and concurrent antihypertensives or CYP3A inhibitors
• Confirm allergy status and verify the MAR shows amlodipine alone or the correct combination product and strength

Contraindications

• Known sensitivity to amlodipine (only labeled contraindication)

Important warnings

• Symptomatic hypotension can occur, particularly in severe aortic stenosis
• Worsening angina or acute myocardial infarction can occur after starting amlodipine or increasing the dose, especially in patients with severe obstructive coronary disease
• Use slow titration and close monitoring in severe hepatic impairment because amlodipine exposure increases
• Amlodipine does not protect against abrupt beta-blocker withdrawal—taper beta-blockers per prescriber orders, not amlodipine alone

Important interactions

↔On a small screen, swipe or scroll sideways to see the full table.

Route: Oral once daily, with or without food per most formulations. Encourage taking the dose at the same time each day for steady blood pressure control.

• Assist older adults and postural-risk patients to sit on the edge of the bed before standing after the first doses
• Do not crush or split extended-release combination products unless pharmacy confirms the specific formulation is safe to modify
• When transitioning from another antihypertensive, clarify whether the prior agent was stopped or tapered—stacking vasodilators increases hypotension risk

• Gradual reduction in blood pressure over days to weeks without symptomatic hypotension
• Decreased angina frequency or improved exercise tolerance when prescribed for coronary disease
• Patient able to change position without dizziness; heart rate may rise slightly from reflex tachycardia but should remain hemodynamically appropriate
• Mild ankle edema may appear at higher doses—distinguish expected drug effect from worsening heart failure using assessment and prescriber input

Hypotension and coronary ischemia can overlap with benign edema or headache. Escalate when hemodynamic or cardiac cues appear.

• Syncope, near-syncope, or sustained systolic hypotension after a dose—hold amlodipine and notify prescriber
• Excessive orthostatic blood pressure drop with dizziness or falls risk
• New or worsening chest pain, especially after starting therapy or increasing dose—evaluate for acute coronary event
• Marked reflex tachycardia with hypotension suggesting overdose or excessive vasodilation
• Rapid weight gain, pulmonary congestion, or dyspnea with edema—may indicate heart failure rather than benign drug edema

↔On a small screen, swipe or scroll sideways to see the full table.

Amlodipine overdose may cause marked hypotension and reflex tachycardia. There is no specific antidote. Hemodialysis is not beneficial.

Supportive management

• Continuous cardiovascular monitoring, IV access, and serial blood pressure and heart rate
• IV fluids for volume expansion when appropriate
• Vasopressors such as phenylephrine for marked hypotension refractory to fluids per prescriber and toxicology guidance
• Contact local poison control or medical toxicology services per facility protocol

• Amlodipine vs amitriptyline / amiodarone—verify generic name on MAR; all are oral tablets but classes and risks differ completely
• Norvasc vs other “-pine” CCBs—do not substitute nifedipine or nicardipine without prescriber order; dosing and duration differ
• Combination products—amlodipine/benazepril or amlodipine/atorvastatin may look like “blood pressure pill” only; confirm components
• Strength confusion—2.5, 5, and 10 mg tablets appear similar; use barcode scanning and independent double-check

↔On a small screen, swipe or scroll sideways to see the full table.

↔On a small screen, swipe or scroll sideways to see the full table.

Monitor

• Blood pressure supine and standing after initiation and dose changes
• Heart rate for reflex tachycardia accompanying hypotension
• Peripheral edema, weight, and symptoms of heart failure when edema appears
• Angina symptoms and chest pain after start or titration

Document

• Dose, time, orthostatic vital signs when protocol requires, and patient-reported dizziness
• Hold events with prescriber notification and response
• Interaction checks (simvastatin dose, CYP3A inhibitors) and patient teaching on slow position changes

• Take once daily at the same time; do not double a missed dose without prescriber guidance
• Stand up slowly and sit before getting out of bed—report dizziness, fainting, or unusual pounding heartbeat
• Ankle swelling can be a medication effect; report sudden weight gain, shortness of breath, or chest pain immediately
• Tell all clinicians about amlodipine before starting new medicines, including over-the-counter and herbal products
• Contact local poison control or toxicology services per facility guidance if too many tablets were taken

Do not give and contact the prescriber/pharmacist when:

Hold parameters may vary by institutional protocol. Follow prescriber orders, pharmacy guidance, and facility policy.

Practice NCLEX-style clinical judgment practice for amlodipine using a tabbed case (MAR, labs, vitals, nursing notes), then priority action, cue recognition, trend interpretation, matrix urgency sorting, overdose management, and hold-rule cloze—recognise cues → analyse → prioritise → act → evaluate outcomes.

This medication guide is written and reviewed using NurseOnShift editorial and clinical review standards.

• Editorial Policy
• Medical Review Process
• Disclaimer

Educational use only. This content does not replace clinical judgment, prescriber orders, pharmacist guidance, product labeling, or institutional protocols.